Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Exelixis
Replimune Inc.
BioNTech SE
Pfizer
Immunophotonics, Inc.
Eikon Therapeutics
TuHURA Biosciences, Inc.
SUNHO(China)BioPharmaceutical CO., Ltd.
Tyme, Inc
Clovis Oncology, Inc.
Novartis
Bristol-Myers Squibb
Oncoscience AG
Sanofi
Sanofi
Bellus Health Inc. - a GSK company
Celgene